hashimoto disease and glp 1 Ozempic & Hashimoto's: Clinical Evidence & Safety – PlexusDx Are GLP-1 Medications Safe for

Diabetes Technol Ther 23(3):213220

Your clinician can also help you understand your potential health risks with: Know Your Heart screenings

For example, gastro-oesophageal reflux disease (GORD) is listed as a common side effect (affecting up to 1 in 10 people) with semaglutide (Wegovy), while dyspepsia (indigestion) is common with several agents in this class

Efficacy of berberine in patients with non-alcoholic fatty liver disease

Wegovy received FDA approval in 2024 to reduce the risk of heart attack, stroke, and cardiovascular death in overweight or obese adults with established heart disease

10.1152/physrev.00034.2006 57 HolstJ